Keros Therapeutics
IPOPowered by TGF-ß science, inspired by patients
Public · Lexington, United States · $97.0M raised
- Headquarters
- Lexington, Massachusetts
- Employees
- 51–200
- Business Model
- B2B
- Website
- kerostx.com
- Total Funding
- $97.0M
- Last Round
- $56.0M Series CJan 2020
- Rounds
- 3
- Type
- Public
About
Clinical-stage biopharmaceutical company focused on developing novel therapeutics for hematological and musculoskeletal diseases.
Summary
Keros Therapeutics is a Biotech company based in Lexington, United States. It has raised $97.0M in total across 3 rounds, most recently a $56.0M Series C round in Jan 2020. Investors include OrbiMed and Foresite Capital.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2020
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...